Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2BSy36u
via IFTTT